Shares of Take Solutions were locked in the 2% upper circuit on Friday, April 17, following the company's strategic announcement. According to reports from LiveMint, the stock opened at an intraday high of ₹48.91 and touched an intraday low of ₹48.85 per share on the BSE. The company's shares have demonstrated exceptional momentum across multiple timeframes, with a remarkable 468.72% return over the past one year, highlighting sustained investor interest in the small-cap stock.
The company announced its entry into India's longevity and anti-aging segment through an exchange filing, as reported by LiveMint. According to the filing, Take Solutions aims to leverage its established capabilities in clinical research, life sciences, and regulatory processes to build a scalable platform spanning consumer health products and digital wellness solutions. The initiative represents a dual approach merging product innovation with technology-driven solutions, featuring science-based nutraceuticals, biohacking products, and predictive digital tools aimed at metabolic health, sleep, cognition, and biological aging.
The global longevity market presents significant growth opportunities, with the market valued at $27.61 billion in 2025 and expected to reach $67.03 billion by 2035, reflecting a CAGR of 9.41%, as reported by LiveMint. In India, the potential is growing in sectors such as anti-aging supplements, services, and preventive healthcare, fueled by increased health awareness and a rise in lifestyle-related health issues. Parmeshvar Dhangare, Director of Take Solutions Ltd, stated that the company aims to build a diversified revenue mix across consumer products, services, and digital platforms while leveraging core strengths in healthcare and regulatory execution.
According to LiveMint reports, Take Solutions shares have delivered strong performance across various timeframes, gaining 7.54% over the past week and surging 18.66% in two weeks. Over a one-month period, the stock is up 23.23%, while in the last three months it has advanced 17.43%. On a broader horizon, the performance remains robust with the stock rising 21.33% on a year-to-date basis and an impressive 138.35% over the past six months, demonstrating sustained investor confidence in the company's strategic direction.
